Hopo Therapeutics News and Activities

Acquisition, funding and merger involving Hopo Therapeutics.

• Hopo Therapeutics has just announced a $226 Million fundraising (posted on November 29 2024).

View the org chart displaying its 6 main executives

Most searched biographies at Hopo Therapeutics

• Julian Rees, Chief Executive Officer
• Hannah Weber, Vice President, Strategy and Business Development
• Laura Vega, Director, Finance Planing and Analysis and Program Con...

Create your alert
to follow the executive moves at Hopo Therapeutics.

Hopo Therapeutics has 2,341 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).

Popular M&A news in Biotechnology

• Regeneron Pharmaceuticals has announced the acquisition of 23andMe  (posted on May 20 2025).
• Stylus Medicine has just announced a $85 Million fundraising (posted on May 16 2025).
• Azafaros has just announced a $132 Million fundraising (posted on May 15 2025).

Popular contacts in Biotechnology

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group
• Deepika Verma - Associate Director of Data Science and Digitalization at Wheeler Bio
• Steven Gillis - Chairman of the Board at VBI Vaccines

Learn more about the Biotechnology industry

Press releases by Hopo Therapeutics

• HOPO Therapeutics Awarded Up to $226 Million from BARDA for Advanced Development of its Oral Decorporation Agent for Heavy Metal Toxicity

Social media about Hopo Therapeutics

• Hopo Therapeutics on Wikipedia, Google News & Yahoo Finance
• Hopo Therapeutics on LinkedIn, Twitter & YouTube